- Mitochondrial cholesterol trafficking: impact on inflammatory mediators
English Grant, Taylor Janice M, Graham Ann, Riaz Asma, Gibbon Amanda
- Mitochondrial Regulation of micro RNA synthesis in Vascular Smooth Muscle Cell Proliferation and Migration
Z Al-Sulti, R McDonald, D Kingsmore, A Baker, P Coats
- Mitochondria-targeted hydrogen sulfide donors potentiate methyl aminolevulinate (MAL)-induced photodynamic therapy killing of skin cancer cells
D Ferguson, A Perry, G Smeardon, M Murphy, A Curnow, M Wood, M Whiteman, PG Winyard
- Mitochondria-targeting doxorubicin: a new therapeutic strategy against doxorubicin-resistant osteosarcoma
I Buondonno, E Gazzano, SR Jean, J Kopecka, IC Salaroglio, C Costamagna, M Serra, D Ghigo, SO Kelley, C Riganti
- Mitogen Activated Protein Kinases and cAMP-dependent Kinases Mediate ?2-Adrenoceptor Dependent Mucin MUC5AC Expression in Normal Human Bronchial Epithelial Cells in Response to IL-13
Al-Sawalha N, Pokkunuri I, Hernandez A, Bond RA, Knoll BJ
- Mitomycin C for refractory caustic ingestion related oesophageal strictures: a review of the evidence for its use.
Mukhtar O, Wood DM, Dargan PI
- ML290, a small allosteric biased agonist at RXFP1
M Kocan, M Sarwar, S Ang, J Xiao, J Marugan, M Hossain, C Wang, D Hutchinson, C Samuel, A Agoulnik, R Bathgate, R Summers
- ML417: a potent and highly selective D3 dopamine receptor agonist
A Moritz, R Free, W Weiner, M Bachani, T Doyle, N Southall, M Ferrer, J Javitch, J Steiner, J Aub‚, K Frankowski, D Sibley
- MLP interacting protein 1 (MIP1) is important for the cardiac stress response, regulates autophagy and is a novel candidate gene for cardiomyopathy
R Knöll, S Kostin, C Mansfield, O Choi, R Isaacson, KL Poon, G Knöll, S Mcsweeney, A Perrot, MR Toliat, J Chen, I Gould, E Lara-Pezzi, P Luther, E Petretto, H Milting, T Brand, P Nürnberg, B Buyandelger
- MMP inhibitors attenuate doxorubicin-induced heart failure by preventing cardiac titin proteolysis
B. Y. Chan1, A. Roczkowsky1, N. Moser1, M. Poirier1, R. Ilarraza1, H. Granzier2, R. Schulz1. 1Pharmacology, University of Alberta, Edmonton, Canada, 2Cellular and Molecular Medicine, University of Arizona, Tucson
